US 10098925
Protein SLURP-1 for use in the treatment of ocular diseases
granted A61KA61K38/1709A61K38/177
Quick answer
US patent 10098925 (Protein SLURP-1 for use in the treatment of ocular diseases) held by Brightpulse Holding Ltd. expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Brightpulse Holding Ltd.
- Grant date
- Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/1709, A61K38/177, A61K47/36, A61K9/0048